Teva stated that if the two companies had been operating as one in 2007, the combined revenue would have been close to USD12bn.
The transaction is expected to close by the end of 2008. Teva Pharmaceutical Industries Limited, at the end of the acquisition, will have operations in more than 60 countries.
Comments on this story may be sent to admin@m2.com

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index